Based on our own work and the published literature, here we provide a summary of the clinical phenotype and molecular architecture of SPENCD, discuss what is known about the function of TRAP, and consider how a loss of TRAP activity might result in a disturbance of innate immunity. The gene discussed is ACP5; the disease is Spondyloenchondrodysplasia with immune dysregulation.